首页> 外文期刊>Oral oncology >Association between oral leukoplakia and upper gastrointestinal cancers: A 28-year follow-up study in the Linxian General Population Trial
【24h】

Association between oral leukoplakia and upper gastrointestinal cancers: A 28-year follow-up study in the Linxian General Population Trial

机译:口腔白斑与上消化道癌之间的关联:临县普通人群试验的28年随访研究

获取原文
获取原文并翻译 | 示例

摘要

Background: Oral leukoplakia is a precancerous disorder that is common among residents in Linxian. However, the associations between oral leukoplakia and upper gastrointestinal cancers have not been reported. We investigated the relationships between oral leukoplakia and upper gastrointestinal cancers in the Linxian General Population Trial cohort.Methods: The Linxian General Population Trial cohort, with 29,584 healthy adults enrolled in 1985 and followed through the end of 2012. With collected baseline data, hazard ratios (HR) and 95% confidence intervals (95% CI) for developing upper gastrointestinal cancers were estimated using Cox proportional hazard models.Results: During 28 years of follow-up, we confirmed a total of 2924 incident esophageal squamous cell carcinoma (ESCC) cases, 1644 gastric cardia cancers and 590 gastric non-cardia cancers. Overall, participants with oral leukoplakia had significantly higher risk of developing ESCC (HR = 1.18, 95% CI: 1.08, 1.29). Among individuals ≤52 years old at baseline, oral leukoplakia was associated with elevated risk of ESCC (HR = 1.31, 95%CI: 1.15, 1.49). No significant associations were observed for gastric cardia or non-cardia cancers in either all subjects or subgroups.Conclusions: Oral leukoplakia was associated with increased risk of ESCC, particularly in younger population. Future studies are needed to confirm these findings.
机译:背景:口腔白斑是一种癌前疾病,在林县居民中很常见。但是,口腔白斑与上消化道癌之间的关联尚未见报道。我们在临县普通人群试验队列中研究了口腔白斑与上消化道癌之间的关系。方法:1985年入Lin县普通人群试验队列的29584名健康成年人,其次是2012年底。通过收集的基线数据,危险比使用Cox比例风险模型评估了上消化道癌的HR(HR)和95%置信区间(95%CI)。结果:在28年的随访中,我们共确认了2924例食管鳞状细胞癌事件。 1644例胃card门癌和590例胃非non门癌。总体而言,患有口腔白斑的参与者罹患ESCC的风险明显更高(HR = 1.18,95%CI:1.08,1.29)。在基线时≤52岁的个体中,口服白斑与ESCC的风险升高相关(HR = 1.31,95%CI:1.15,1.49)。在所有受试者或亚组中,均未观察到胃card门癌或非significant门癌的显着相关性。结论:口腔白斑与ESCC风险增加相关,尤其是在年轻人群中。需要进一步的研究来证实这些发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号